A new method for testing how drugs are cleared from the body
Official title: Hepatic Clearance Chip for Pharmacokinetics
Funded at Javelin Biotech · NIH-10916498 · Data updated 2026-11-12
This study is working on a new device that mimics how the human liver processes medications, which could help researchers develop safer and more effective drugs faster, ultimately benefiting patients like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Javelin Biotech NIH-funded |
| Lab location | 1 site (Woburn, UNITED STATES) |
| Project start | August 30, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $974,458 |
| NIH project number | 5R44TR004524-02 |
| Project ID | NIH-10916498 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals involved in drug development or those interested in the pharmaceutical industry's approach to drug testing.
✕Less likely to help
Patients who are not involved in drug development or who do not have a vested interest in pharmaceutical testing may not receive direct benefits from this research.
What this research studies
This research focuses on developing a novel hepatic clearance chip that aims to improve drug metabolism and pharmacokinetic testing (DMPK). By creating a more predictive and cost-effective alternative to traditional animal models, this approach seeks to streamline the drug development process. The chip will simulate human liver function, allowing for better understanding of how drugs are processed in the body, which could lead to faster and more reliable results. Patients may benefit from this research as it could lead to safer and more effective medications entering clinical trials sooner.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time and cost associated with drug development, leading to more effective treatments for patients.
How similar studies have gone: While there have been attempts to improve DMPK testing through in vitro methods, this specific approach using a hepatic clearance chip is relatively novel and has not been widely tested.
Where this research is happening
-
Javelin Biotech
Woburn, United States Active
Researchers
- Principal investigator: Cirit, Murat — Javelin Biotech
- Study coordinator: Cirit, Murat
Related research
Other NIH-funded projects on the same topics.
-
Sub-second acetylcholine release in the brain for Alzheimer’s dementia
A small, quick stimulations-based study aims to boost a brain chemical called acetylcholine to help people with Alzheimer’s disease by using a targeted brain stimulation approach.
-
Understanding how broadly neutralizing antibodies may help HIV cure trials
A study at UC San Francisco looks at how antibody medicines behave in people on and off HIV therapy to help design better cure strategies.
-
Improving HIV-related brain infections by studying how drugs reach the brain
This grant looks at how well drugs reach the brain and spine to treat HIV-related infections like cryptococcal meningitis and TB meningitis in people with AIDS.
-
Transdermal delivery patch for zanamivir to treat influenza in patients
A new skin patch delivers zanamivir to people with flu or at risk of flu, aiming for easier, safer treatment than pills.
-
Chesapeake-Ohio Pharmacokinetics Core supports cancer drug testing
A collaborative core lab helps researchers study how cancer drugs behave in the body to improve clinical trials and patient care.
-
Urine color test to check tuberculosis drug levels in children and adults
This project uses a simple urine color test to see whether children and adults with TB are getting enough of key TB medicines like rifampin.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.